statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Mira Pharmaceuticals Announces Encouraging Preclinical Results Advancing Ketamir-2 Towards Potential Year-End IND Submission Mira Pharmaceuticals Announces Encouraging Preclinical Results Advancing...

Mira Pharmaceuticals Announces Encouraging Preclinical Results Advancing Ketamir-2 Towards Potential Year-End IND Submission

MIRA Pharmaceuticals Welcomes Dr. Itzchak Angel, former Head of Pharmacology at Synthelabo, as Chief Scientific Advisor MIRA Pharmaceuticals Welcomes Dr. Itzchak Angel, former Head of Pharmacology at...

MIRA Pharmaceuticals Welcomes Dr. Itzchak Angel, former Head of Pharmacology at Synthelabo, as Chief Scientific Advisor

MIRA Pharmaceuticals' revelation on MIRA1a. Uncover MIRA-55, a potent oral marijuana drug candidate for anxiety and cognitive decline.
read more...

Medical Marijuana-Focused Mira Pharmaceuticals Stock Surges After Neuropsychiatric Disorders Update - Here's Why

Gagnants
Le titre Psyence Biomedical (NASDAQ:PBM) a grimp vendredi de 146,36% 3,13 dollars lors de la session ordinaire.
L'action Ainos (NASDAQ:AIMD) a grimp de 88,36% 2,11 dollars.
Le titre...

12 titres de soins de sant  en mouvement lors de la session du 08/03/2024

MIRA Pharmaceuticals Provides Corporate Update MIRA Pharmaceuticals Provides Corporate Update PR Newswire BALTIMORE, Feb. 5, 2024 Announces Research Collaboration with Pharmaseed to Conduct...

MIRA Pharmaceuticals Provides Corporate Update

Shares of MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA  Get Free Report) dropped 4.4% during mid-day trading on Wednesday . The stock traded as low as $0.86 and last traded at $0.87. Approximately...

MIRA Pharmaceuticals (NASDAQ:MIRA)  Shares Down 4.4%

MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company engages in developing its product candidate, MIRA1a, as a synthetic cannabinoid analog for treating anxiety & chronic pain by targeting the cannabinoid type 1 and type 2 (CB1 and CB2) receptors. MIRA Pharmaceuticals was founded by Adam Kaplin on September 3, 2020 and is headquartered in Miami, FL.

Watchers	456
52-Wk Low	$0.72
52-Wk High	$7.98

Volume	9,223.00
52-Wk High	$7.98
52-Wk Low	$0.72

MIRA MIRA PHARMACEUTICALS INC

About

Feed

News

Fundamentals